用户名: 密码: 验证码:
HPLC法测定载5-取代-1-氮杂蒽醌类衍生物氧化石墨纳米粒中的药物含量
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Determination of 5-Substituted 1-Alkaloids with Azaanthraquinone Skeleton (A1)-loaded Graphite Oxide Nanoparticles by HPLC
  • 作者:王凌峰 ; 蒲志军 ; 李明新 ; 李镇 ; 陈薇
  • 英文作者:Wang Lingfeng;Pu Zhijun;Li Mingxin;Li Zhencheng;Chen Wei;College of Pharmacy,Guilin Medical University;Affiliated Hospital of Guilin Medical University;
  • 关键词:5-取代-1-氮杂蒽醌类衍生物 ; 氧化石墨 ; 纳米粒 ; 高效液相色谱法 ; 含量测定
  • 英文关键词:5-Substituted 1-a-lkaloids with azaanthraquinone skeleton;;Graphite oxide;;Nanoparticles;;HPLC;;Content determination
  • 中文刊名:ZYSG
  • 英文刊名:China Pharmacist
  • 机构:桂林医学院药学院;桂林医学院附属医院;
  • 出版日期:2019-02-05
  • 出版单位:中国药师
  • 年:2019
  • 期:v.22
  • 基金:广西省科技厅重大专项(编号:桂科AA17292001)
  • 语种:中文;
  • 页:ZYSG201902051
  • 页数:3
  • CN:02
  • ISSN:42-1626/R
  • 分类号:177-179
摘要
目的:建立氧化石墨纳米粒中氮杂蒽醌类生物碱A1化合物含量测定的HPLC方法。方法:色谱柱为Inertsil ODS-3柱(250 mm×4. 6 mm,5μm);以甲醇-水-三乙胺(65∶35∶0. 05)为流动相;流速为1. 0 ml·min~(-1);检测波长为243 nm;柱温为30℃;进样体积为20μl。结果:A1的质量浓度在1. 00~100. 00μg·ml~(-1)线性关系良好(r=1. 000 0),平均加样回收率为102. 8%(RSD=1. 79%,n=9)。结论:该含量测定方法准确可靠、简单易行,可用于氧化石墨纳米粒中A1化合物的含量测定。
        Objective: To establish an HPLC method for the determination of alkaloids in 5-substituted 1-alkaloids with azaanthraquinone skeleton (A1)-loaded graphite oxide nanoparticles. Methods: An Inertsil ODS-3 column (250 mm × 4. 6 mm,5 μm) was used with methanol-water-triethylamine (65 ∶ 35 ∶ 0. 05) as the mobile phase at the flow rate of 1. 0 ml·min~(-1). The A1 was detected at 243 nm. The column temperature was 30℃,and the injection volume was 20 μl. Results: The linear range of A1 was 1. 00-100. 00μg·ml~(-1) (r = 1. 000 0). The average recovery was 102. 8% (RSD = 1. 79%,n = 9). Conclusion: The method is accurate,reliable and simple,and can be used for the determination of A1 compound in graphite oxide nanoparticles.
引文
1赵媛媛,殷婷婕,霍美蓉,等.石墨烯及其衍生物氧化石墨烯作为新型药物载体材料在肿瘤治疗领域的应用研究[J].药学进展,2015,39(1):32-39
    2马娜新.非共价功能化修饰的氧化石墨烯作为抗癌药物载体的研究[D].济南:山东大学硕士学位论文,2017
    3龚水水,光善仪,柯福佑,等.红外光谱法氧化石墨烯羧基官能团含量的测定[J].中国测试,2016,42(4):38-44
    4 Muthoosamy K,Abubakar IB,Bai RG,et al.Exceedingly Higher co-loading of Curcumin and Paclitaxel onto Polymer-functionalized Reduced Graphene Oxide for Highly Potent Synergistic Anticancer Treatment[J].Sci Rep,2016,6:32808
    5 Thapa RK,Byeon JH,Ku SK,et al.Easy on-demand self-assembly of lateral nanodimensional hybrid graphene oxide flakes for near-infrared-induced chemothermal therapy[J].Npg Asia Materials,2017,9(8):e416
    6 Wu SY,An SS,Hulme J.Current applications of graphene oxide in nanomedicine[J].Int J Nanomedicine,2015,10:9-24
    7 Hung AH,Holbrook RJ,Rotz MW,et al.Graphene oxide enhances cellular delivery of hydrophilic small molecules by co-incubation[J].Acs Nano,2014,8(10):10168
    8邢欢欢.5-取代-1-氮杂蒽醌类衍生物A7对氧化应激诱导的AD细胞毒性的抑制作用及其机制[D].广西桂林:桂林医学院硕士学位论文,2017
    9胡观明.蒽醌类化合物的合成及对肿瘤细胞的细胞毒活性的研究[D].兰州:兰州大学硕士学位论文,2014
    10陈芊,楚英豪.Hummers法制备氧化石墨烯[J].四川化工,2016,19(2):14-16
    11史士强,纪宏宇,唐景玲,等.HPLC法测定载多柔比星氧化石墨纳米粒中的药物含量[J].中国药师,2013,16(3):334-336
    12 Liu Z,Robinson JT,Sun X,et al.PEGylated Nano-Graphene Oxide for Delivery of Water Insoluble Cancer Drugs[J].J Am Chem Soc,2008,130(33):10876-10877
    13 Huang P,Wang S,Wang X,et al.Surface Functionalization of Chemically Reduced Graphene Oxide for Targeted Photodynamic Therapy[J].J Biomed Nanotechnol,2015,11(1):117-125

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700